Kato Hiroyuki 加藤宏之

Researcher Number	50737004
Affiliation (Current)	2025: 藤田医科大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2023: 藤田医科大学, 医学部, 准教授 2021 – 2022: 藤田医科大学, 医学部, 講師 2016 – 2020: 三重大学, 医学部附属病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 55020:Digestive surgery-related / Digestive surgery Except Principal Investigator Gastroenterology
Keywords	Principal Investigator 脂肪肝 / 細胞外マトリックス / PARP1 / 肝移植 / Ischemia reperfusion / 非ウイルス性肝癌 / 虚血再灌流障害 / 虚血再灌流傷害 / 予後不良肝癌 / 肝細胞癌 … More / 膵外分泌機能 / ・ラット / マウス / NAFLD / 膵頭十二指腸切除 … More Except Principal Investigator 新規臨床病期システム / 局所進行膵癌 / 境界切除可能膵癌 / 局所進行切除不能膵癌 / 免疫栄養指標 / 化学放射線治療 / 生物学的悪性度 / 浸潤性膵管癌 Less

PARP-1に着目した脂肪肝虚血再灌流障害の増悪機序の解明Principal Investigator
- Principal Investigator
  
  加藤宏之
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Fujita Health University
Translational research for elucidating the clinicopathological characteristics of non-viral hepatocellular carcinomaPrincipal Investigator
- Principal Investigator
  
  Kato Hiroyuki
- Project Period (FY)
  2018 – 2019
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Mie University
Establishment and therapeutic application of a new clinical staging system based on the biological features of pancreatic adenocarcinoma
- Principal Investigator
  
  Isaji Shuji
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Mie University
Molecular basis study for revealing the pathogenesis of NAFLD after pancreatic resection focusing on extracellular matrixPrincipal Investigator
- Principal Investigator
  
  Kato Hiroyuki
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Mie University

All 2023 2022 2020 2019 2018 2017 Other

All Journal Article Presentation Book Other

[Book] 膵頭十二指腸切除（PD）後の脂肪肝2018
- Author(s)
  坂口充弘、飯澤祐介、藤井武宏、加藤宏之、伊佐地秀司
- Publisher
  医学図書出版
- Data Source
  KAKENHI-PROJECT-16K19917
[Journal Article] Right hepatectomy with preservation of the entire caudate lobe in patients with metastatic liver tumors: a case of a new hepatectomy technique and treatment strategy for patients with marginal liver function2022
- Author(s)
  Kato Hiroyuki、Asano Yukio、Ito Masahiro、Arakawa Satoshi、Kawabe Norihiko、Shimura Masahiro、Koike Daisuke、Hayashi Chihiro、Ochi Takayuki、Kamio Kenshiro、Kawai Toki、Yasuoka Hironobu、Higashiguchi Takahiko、Horiguchi Akihiko
- Journal Title
  
  BMC Surgery
  
  Volume: 22 Issue: 1 Pages: 1-5
- DOI
  10.1186/s12893-022-01478-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K08696
[Journal Article] Significant positive impact of duodenum‐preserving pancreatic head resection on the prevention of postoperative nonalcoholic fatty liver disease and acute cholangitis2022
- Author(s)
  Kato Hiroyuki、Asano Yukio、Ito Masahiro、Arakawa Satoshi、Shimura Masahiro、Koike Daisuke、Hayashi Chihiro、Kamio Kenshiro、Kawai Toki、Horiguchi Akihiko
- Journal Title
  
  Annals of Gastroenterological Surgery
  
  Volume: 6 Issue: 6 Pages: 851-861
- DOI
  10.1002/ags3.12593
- Data Source
  KAKENHI-PROJECT-21K08696
[Journal Article] Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma2020
- Author(s)
  Kato Hiroyuki、Kishiwada Masashi、Hayasaki Aoi、Chipaila Jackson、Maeda Koki、Noguchi Daisuke、Gyoten Kazuyuki、Fujii Takehiro、Iizawa Yusuke、Tanemura Akihiro、Murata Yasuhiro、Kuriyama Naohisa、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji、Mizuno Shugo
- Journal Title
  
  Annals of Surgery
  
  Volume: - Issue: 5 Pages: e698-e707
- DOI
  10.1097/sla.0000000000004148
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients2019
- Author(s)
  Ichikawa Ken、Mizuno Shugo、Hayasaki Aoi、Kishiwada Masashi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Murata Yasuhiro、Azumi Yoshinori、Kuriyama Naohisa、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Cancers
  
  Volume: 11(4) Issue: 4 Pages: 514-514
- DOI
  10.3390/cancers11040514
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy2019
- Author(s)
  Jaseanchiun Warakorn、Kato Hiroyuki、Hayasaki Aoi、Fujii Takehiro、Iizawa Yusuke、Tanemura Akihiro、Murata Yasuhiro、Azumi Yoshinori、Kuriyama Naohisa、Kishiwada Masashi、Mizuno Shugo、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Pancreatology
  
  Volume: 19(2) Issue: 2 Pages: 307-315
- DOI
  10.1016/j.pan.2019.01.020
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019
- Author(s)
  Hayasaki Aoi、Murata Yasuhiro、Usui Masanobu、Hibi Taemi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Azumi Yoshinori、Kuriyama Naohisa、Kishiwada Masashi、Mizuno Shugo、Sakurai Hiroyuki、Uchida Katsunori、Isaji Shuji
- Journal Title
  
  BioMed Research International
  
  Volume: 2019 Pages: 1-12
- DOI
  10.1155/2019/5738614
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor2019
- Author(s)
  Takeuchi Taijiro、Mizuno Shugo、Murata Yasuhiro、Hayasaki Aoi、Kishiwada Masashi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Kuriyama Naohisa、Azumi Yoshinori、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Pancreas
  
  Volume: 48(2) Issue: 2 Pages: 281-291
- DOI
  10.1097/mpa.0000000000001227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019
- Author(s)
  Takeuchi T, Mizuno S, Murata Y, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Kuriyama N, Azumi Y, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  Pancreas.
  
  Volume: 48(2) Pages: 281-291
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.2019
- Author(s)
  Jaseanchiun W, Kato H, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  Pancreatology.
  
  Volume: 19(2) Pages: 307-315
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.2019
- Author(s)
  Ichikawa K, Mizuno S, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Isaji S
- Journal Title
  
  Cancers (Basel).
  
  Volume: 11(4).
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.2018
- Author(s)
  Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H.
- Journal Title
  
  Cancers (Basel).
  
  Volume: 10(3)
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Different roles of pancreatic duct dilatation and remnant pancreatic volume for the development of pancreatic endocrine and exocrine dysfunction.2017
- Author(s)
  Iizawa Y, Kato H, Kishiwada M, Hayasaki A, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  pancreatology
  
  Volume: 17 Issue: 5 Pages: 814-821
- DOI
  10.1016/j.pan.2017.06.008
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K19917
[Presentation] 肝切除術の未来-腹腔鏡vsロボット-　低侵襲肝切除術　ロボットはスタンダードアプローチになるか?2023
- Author(s)
  加藤悠太郎
- Organizer
  日本内視鏡外科学会
- Data Source
  KAKENHI-PROJECT-21K08696
[Presentation] 腹腔鏡にて切除した肝後区域原発細胆管細胞癌の1例2023
- Author(s)
  加藤宏之
- Organizer
  日本内視鏡外科学会
- Data Source
  KAKENHI-PROJECT-21K08696
[Presentation] 脂肪肝虚血再灌流障害におけるPARP-1阻害薬の細胞保護効果に関する基礎研究2022
- Author(s)
  加藤宏之
- Organizer
  日本移植学会
- Data Source
  KAKENHI-PROJECT-21K08696
[Presentation] 切除可能膵癌における術前化学放射線治療の治療成績　biological borderline膵癌に対する有効性の検討2020
- Author(s)
  村田泰洋, 早崎碧泉, 飯澤裕介, 藤井武宏, 加藤宏之, 種村彰洋, 栗山直久, 岸和田昌之, 水野修吾, 櫻井洋至, 伊佐地秀司
- Organizer
  第120回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 長期成績からみた膵癌に対する集学的治療の評価　局所進行切除不能膵癌に対する化学放射線先行療法後の治療成績2020
- Author(s)
  岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 加藤宏之, 村田泰洋, 種村彰洋, 栗山直久, 水野修吾, 櫻井洋至, 伊佐地秀司
- Organizer
  第120回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌における術前化学放射線治療の臨床的意義　術後早期再発症例の検討2019
- Author(s)
  村田泰洋, 早崎碧泉, 飯澤裕介, 藤井武宏, 加藤宏之, 種村彰洋, 栗山直久, 安積良紀, 岸和田昌之, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行切除不能膵癌に対するConversion surgeryの適応決定における術前癌胎児性抗原(CEA)の重要性　術直前CEA値と切除後予後に着目した臨床的研究2019
- Author(s)
  加藤宏之, 岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 村田泰洋, 種村彰洋, 安積良紀, 栗山直久, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌に対する術前化学放射線療法の治療成績　動脈浸潤と組織学効果に注目して2019
- Author(s)
  岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 加藤宏之, 村田泰洋, 種村彰洋, 栗山直久, 安積良紀, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第50回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Treatment strategy for R and BR pancreatic cancer patients undergoing preoperative chemoradiotherapy according to anatomical, biological and conditional factors2019
- Author(s)
  Shugo Mizuno, Aoi Hayasaki, Masashi Kishiwada, Hiroyuki Kato, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Yoshinori Azumi, Masanobu Usui, Hiroyuki Sakurai, Shuji Isaji
- Organizer
  第31回日本肝胆膵外科学会・学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 予後不良肝癌，いわゆるfluminant hepatocellular carcinomaの臨床的特徴とその治療成績2019
- Author(s)
  加藤宏之
- Organizer
  日本消化器外科学会
- Data Source
  KAKENHI-PROJECT-18K16350
[Presentation] Impact of preoperative chemoradiotherapy for unresectable locally advanced pancreatic cancer paying attention to pre- and post-CRT biological and conditional factors2019
- Author(s)
  Masashi Kishiwada, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Hiroyuki Kato, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Yoshinori Azumi, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Shuuji Isaji
- Organizer
  第31回日本肝胆膵外科学会・学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 放射線化学療法の抗腫瘍効果に着目した膵癌治療前予後予測におけるノモグラムの有用性2018
- Author(s)
  加藤　宏之、岸和田　昌之、早崎　碧泉、藤井　武宏、飯澤　祐介、種村　彰洋、村田　泰洋、栗山　直久、安積　良紀、水野　修吾、臼井　正信、櫻井　洋至、小椋　透、伊佐地　秀司
- Organizer
  第49回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌患者における化学放射線治療施行前後での炎症/免疫栄養指標と予後との関連性について2018
- Author(s)
  市川　健、水野修吾、早崎碧泉、岸和田昌之、飯澤祐介、加藤宏之、村田泰洋、種村彰洋、栗山直久、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第118回日本外科学会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所性膵癌に対する化学放射線療法施行例における炎症/免疫栄養指標と予後の関係2018
- Author(s)
  市川　健、水野　修吾、早崎　碧泉、岸和田　昌之、飯澤　祐介、加藤　宏之、村田　泰洋、種村　彰洋、栗山　直久、臼井　正信、櫻井　洋至、伊佐地　秀司
- Organizer
  第49回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌における術前放射線化学療法施行後、遠隔転移発生の危険因子解析2017
- Author(s)
  加藤　宏之、水野修吾、早崎碧泉、尭天一亨、飯澤祐介　種村彰洋、村田泰洋、安積良紀、栗山直久、岸和田昌之、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第48回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Predictive nomogram for interval distant metastases of locally advanced pancreatic ductal carcinoma after preoperative gemcitabine based chemoradiotherapy. -Clinical importance of biological and physiological markers-2017
- Author(s)
  加藤　宏之、水野修吾、小倉透、早崎碧泉、岸和田昌之、栗山直久、安積良紀、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第29回　肝胆膵外科学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌の治療前予後予測を目的としたPredictive nomogramの作成2017
- Author(s)
  加藤　宏之、岸和田昌之、水野修吾、尭天一亨、早崎碧泉、飯澤祐介、種村彰洋、村田泰洋、安積良紀、栗山直久、臼井正信、櫻井洋至、小倉透、伊佐地秀司
- Organizer
  JDDW2017
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌に対する治療前予後予測は可能か？- 放射線化学療法前予後因子の解析とpredictive nomogramの作成-2017
- Author(s)
  加藤　宏之、岸和田昌之、尭天一亨、早崎碧泉、松井俊樹、飯澤祐介、種村彰洋、村田泰洋、安積良紀、栗山直久、水野修吾、臼井正信、櫻井洋至、伊佐地秀司、小椋透
- Organizer
  第117回日本外科学会
- Data Source
  KAKENHI-PROJECT-17K09459
[]

1. Isaji Shuji (70176121)

# of Collaborated Projects: 1 results

# of Collaborated Products: 23 results
2. 村田泰洋 (20572655)

# of Collaborated Projects: 1 results

# of Collaborated Products: 22 results
3. 水野修吾 (70335131)

# of Collaborated Projects: 1 results

# of Collaborated Products: 23 results
4. 岸和田昌之 (40501961)

# of Collaborated Projects: 1 results

# of Collaborated Products: 23 results

Kato Hiroyuki 加藤 宏之

Research Projects

Research Products

Co-Researchers

PARP-1に着目した脂肪肝虚血再灌流障害の増悪機序の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Translational research for elucidating the clinicopathological characteristics of non-viral hepatocellular carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment and therapeutic application of a new clinical staging system based on the biological features of pancreatic adenocarcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular basis study for revealing the pathogenesis of NAFLD after pancreatic resection focusing on extracellular matrixPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 膵頭十二指腸切除（PD）後の脂肪肝2018

Author(s)

Publisher

Data Source

[Journal Article] Right hepatectomy with preservation of the entire caudate lobe in patients with metastatic liver tumors: a case of a new hepatectomy technique and treatment strategy for patients with marginal liver function2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Significant positive impact of duodenum‐preserving pancreatic head resection on the prevention of postoperative nonalcoholic fatty liver disease and acute cholangitis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019

Author(s)

Journal Title

Data Source

[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.2019

Author(s)

Journal Title

Data Source

[Journal Article] Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.2019

Author(s)

Journal Title

Data Source

[Journal Article] Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.2018

Kato Hiroyuki 加藤宏之

[Presentation] 肝切除術の未来-腹腔鏡vsロボット-　低侵襲肝切除術　ロボットはスタンダードアプローチになるか?2023

[Presentation] 切除可能膵癌における術前化学放射線治療の治療成績　biological borderline膵癌に対する有効性の検討2020

[Presentation] 長期成績からみた膵癌に対する集学的治療の評価　局所進行切除不能膵癌に対する化学放射線先行療法後の治療成績2020

[Presentation] 切除可能膵癌における術前化学放射線治療の臨床的意義　術後早期再発症例の検討2019

[Presentation] 局所進行切除不能膵癌に対するConversion surgeryの適応決定における術前癌胎児性抗原(CEA)の重要性　術直前CEA値と切除後予後に着目した臨床的研究2019

[Presentation] 局所進行膵癌に対する術前化学放射線療法の治療成績　動脈浸潤と組織学効果に注目して2019